The ILCA 2023 Annual Conference Virtual Experience offers participants...

• Access to recorded content presented at the ILCA 2023 Conference by experts from around the world
• The opportunity to earn more than 20 CERPs, nursing contact hours, and CME credits through  session recordings from the In-person Conference and exclusive virtual content

Virtual Experience Pricing

All pricing listed in USD. If you are eligible for equity pricing, please use the discount codes below. Your registration may be revoked if you use a registration code for which you are not eligible.

To determine the country category that matches the country in which you reside, click here.

Included Sessions:

• Opening Remarks and Plenary Session - Challenges and Opportunities in the Global Lactation Consultant Profession
• Plenary Session - Building Policy Coalitions: A Case Study of Reframing Breastfeeding Around ‘First Food Security’ in Australia
• Plenary Session - Investing in Transformative Care Policy Packages: Parental Leave that Supports a Healthy and More Equal World
• Plenary Session - The Human Milk Microbiome: Using Space Science Technology to Better Understand the Association of Milk Microbiota with Breastfeeding Practices and Infant Growth at Different Stages of Lactation
• Closing Remarks and Plenary Session - Human Milk Feeding and Justice: First Do No Harm
• Adoptive Breastfeeding: Journey from Personal Experience to Professional Expertise
• Comparative Assessment of Pulse Light Treatment and Holder Pasteurization on Nutritional, Physicochemical, Antioxidant and Microbiological Profile of Human Milk
• Effect of "Teté Dance" on the Duration of the Lactation Session in Irritable Infants in Perú
• Engaging Health Insurers to Build Equity-Driven Support for Breast/Chestfeeding in Hawai'i
• Examining the Implementation of Baby-Friendly Hospital Initiative in Australia and Indonesia: Using Non Adoption, Abandonment, Scale Up, Spread and Sustainability (NASSS) Framework
• Instagram and the IBCLC: Ethics, Privacy, Misinformation and Maternal Mental Health
• It’s Not All About the Ovaries: Supporting Lactation with PCOS
• Legal, Ethical, or Moral: What Matters Most for Lactation Clinicians?  Does Patient-Centered Care Ever Put the Caregiver at Risk?
• Mastitis Between Clinical and Pathological Diagnosis
• Maternal Weaning in Children Older than 1 year and Parenting Skills
• New and Innovative Pathways to Train a Diverse Future Lactation Workforce
• Supporting the Neurodivergent Family: A Full Team Approach
• When Release Isn't Enough. Persistent Problems Post Tongue Tie Release: Perspectives from a Release Provider IBCLC

Cow's Milk Protein Intolerance (CMPI) is commonly diagnosed by primary care providers in response to parent reports of infant fussiness. For treatment, the provider will recommend elimination of dairy from the nursing parent's diet. However, without appropriate oversight from an informed provider, parents may end up on an overly restrictive diet, causing unnecessary stress and concern for inadequate nutritional intake in certain populations. Understanding the difference between infant allergic disorders and ways that elimination diets can be supported in nursing parents without unnecessary dietary restriction can help to improve the parent's experience with nursing and avoid nutrient deficiencies. IBCLCs can provide necessary support for nursing parent's whose child is experiencing suspected CMPI and can help to provide appropriate referrals in the event that symptoms do not resolve.

Credit: 1.00 L CERP and 1.00 Contact Hours

Source: ILCA Webinar 7 July 2023

Presented by: Hope Lima, PhD, RDN, IBCLC

Upon completion, the learner will be able to: 

• List two signs/symptoms that may indicate the need for referral to a dietitian to oversee an elimination diet.
• Describe the difference between an IgE and non-IgE mediated allergic response.
• List diagnostic criteria for FPIAP, FPIES, and GERD.
• Define the basic structure of an elimination diet.
• Describe the possible impacts of unaddressed dietary allergen exposure in the breastfed infant.

Learning Level: Intermediate

Expiration Date: 7 July 2025

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. The presenter has no significant financial interest or other relationship with the manufacturer(s) of any product(s) or provider(s) of any services relating to the subject matter of this presentation unless otherwise stated below.

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

ANCC: ILCA is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Approval Number ILCA-P0286. Accepted for BRN credit by the Board of Registered Nursing.

ILCA education is provided as a service to our members for continuing education, knowledge, and awareness. We believe in fostering an inclusive environment that supports diversity and removes barriers. The views and opinions expressed in this education, including the choice of vocabulary, expressions, and use of supporting evidence-based research belong to the presenter. ILCA is steadfast in our commitment to present, learn, and discuss any information in a safe, respectful, and supportive environment.

Abstract: Multi-systemic, poorly understood, under-researched and under-diagnosed, Hypermobility Spectrum Disorders (HSD) and the Ehlers-Danlos Syndromes are genetic anomalies that can cause challenges to the breastfeeding relationship both directly, through acute interfering symptoms in the nursing parent or infant, and indirectly through birth trauma and injury. Lactation professionals should understand the basic challenges caused by HSD as well as have strategies to support families with this rare disease which may not be very rare at all (Demmler et al 2019). This presentation discusses signs and symptoms of HSD which may affect the breastfeeding relationship and how the lactation consultant may address these challenges on an individual basis. I present two cases in which the nursing parent had Ehlers-Danlos Syndrome Type 3; breastfeeding challenges in these cases were similar with excessive infant weight loss in the beginning which was overcome with appropriate supplementation and close follow up. I also discuss how HSD may affect lactation indirectly through increased risk of a difficult birth including malpresentation, injury and prolapse and how to overcome these challenges. Last, I briefly discuss how three conditions which often co-occur with HSD - autonomic dysfunction, mast cell activation disorders, and neurodivergence - can be sensitively addressed within the breastfeeding relationship while meeting the needs of each family.

Publication: Presentation has not been published.

Diversity and Inclusion: Supporting breastfeeding families well involves supporting the best hormonal and neurological states for learning, healing and milk production. The language that we use and stories we tell have a strong impact upon the brains of our clients, for better or for worse. Using language that includes everyone increases our patients? emotional safety and allows them to work with us effectively. In my presentations, I use gender inclusive language such as modeling pronoun use for the gender spectrum and using gender neutral descriptors such as ?the breastfeeding/chestfeeding parent.? I have done a world-wide literature search on my topic since Hypermobility Spectrum Disorders and EDS can affect anyone from any culture or economic background. I also use language which includes the broadest definitions of family and all sexual orientations as these words allow for inclusion and can lower stress hormones.

Upon the completion of the education, the learner will be able to:

1. Identify four major signs and symptoms of Hypermobility Spectrum Disorders and Ehlers-Danlos Syndromes

2. Discuss how HSD and EDS can affect the breastfeeding/chestfeeding relationship

3. Collaborate with HSD and EDS patients to develop an individualized breastfeeding/chestfeeding care plan

4. Execute referrals to medical and support resources for breastfeeding/chestfeeding HSD and EDS patients and their infants

Credit: 1.00 L CERP and 1.00 Contact Hours

Source: ILCA 2022 Annual Conference

Presented by: Adrienne Fuson, IBCLC, Lactation Solutions NW

Learning Level: Intermediate

Expiration Date: 31 December 2023

IBLCE Category: Pathology

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. The presenter has no significant financial interest or other relationship with the manufacturer(s) of any product(s) or provider(s) of any services relating to the subject matter of this presentation unless otherwise stated below.

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

ANCC: ILCA is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Approval Number ILCA-P0286. Accepted for BRN credit by the Board of Registered Nursing.

ILCA education is provided as a service to our members for continuing education, knowledge, and awareness. We believe in fostering an inclusive environment that supports diversity and removes barriers. The views and opinions expressed in this education, including the choice of vocabulary, expressions, and use of supporting evidence-based research belong to the presenter. ILCA is steadfast in our commitment to present, learn, and discuss any information in a safe, respectful, and supportive environment.

Abstract: Recreational use of marijuana is approved for people >21 without clear guidelines/restrictions for pregnant/breastfeeding women. Although it is illegal at the Federal level, thirty-six states have legalized the use of marijuana medicinally; and eighteen states, including New Jersey, and Washington D.C. have legalized the use of cannabis recreationally. Women who live in states with legalized recreational cannabis are significantly more likely to use cannabis compared to women in states without legalized recreational cannabis. A perception of safety in pregnancy and increased social acceptance of cannabis6 may contribute to one in 25 pregnant women use marijuana during pregnancy; 16.8% of women used cannabis in the pre-conception, 5.5% in the prenatal, and 6.6% in the postpartum periods. Women use it for stress/anxiety relief, as antiemetic, to increase appetite, as a sleep aid, for pain relief, and for depression. With about 500 chemicals, including the mind-altering compound tetrahydrocannabinol (THC), marihuana can pass through a woman?s placenta to her baby during pregnancy. It can have negative effects on maternal/fetal outcomes on long-term brain development issues affecting memory/learning, and behavior, increased preterm birth, and low birth-weight, increased risk for and schizophrenia. Potency has increased six-seven-fold since the 1970s. One in 10 individuals over the age of 18 years and 1 in 6 under the age of 18 years will become addicted. This systematic review will examine the responsibility and the role of the interdisciplinary team and lactation consultant in educating women to prevent unintended consequences of the use of recreational marijuana.

Publication: N/A

Diversity and Inclusion: All content, language, and references are diverse and inclusive relevant to all cultures, genders, family structures, social groups, and geographic settings.

Speaker: Maryelena Vargas, PhD, CCNE

Upon completion of this education, the learner will be able to:

1. Describe effects of marijuana use on fetal outcomes

2. Describe effects of marijuana use on breastfeeding children's outcomes

3. Acknowledge responsibilities/role of the interdisciplinary team/lactation consultant on educating pregnant/breastfeeding women about use of marijuana during pregnancy/breastfeeding

4. Interpret evidence available to determine specific methods to increase awareness/educate pregnant/breastfeeding women about effects of use of marijuana during pregnancy/breastfeeding

Learning Level: Beginner, Intermediate, Advanced

IBLCE Category: Pharmacology & Toxicology

Expiration Date: 30 November 2023

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. The presenter has no significant financial interest or other relationship with the manufacturer(s) of any product(s) or provider(s) of any services relating to the subject matter of this presentation unless otherwise stated below.

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

ANCC: ILCA is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Approval Number ILCA-P0286. Accepted for BRN credit by the Board of Registered Nursing.

ILCA education is provided as a service to our members for continuing education, knowledge, and awareness. We believe in fostering an inclusive environment that supports diversity and removes barriers. The views and opinions expressed in this education, including the choice of vocabulary, expressions, and use of supporting evidence-based research belong to the presenter. ILCA is steadfast in our commitment to present, learn, and discuss any information in a safe, respectful, and supportive environment.

Gain access to 5 CERPS to support your IBCLC Recertification Journey with our 2022 Conference Recordings Bundle. Each recorded session is worth 1.0 CERP. Contains 4.0 L-CERP and 1.0 E-CERP.

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. 

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

All pricing listed in USD. If you are eligible for equity pricing, please use the discount codes below. Your registration may be revoked if you use a registration code for which you are not eligible.

To determine the country category that matches the country in which you reside, click here.

Gain access to 5 E-CERPS to support your IBCLC Recertification Journey with our 2022 Conference Recordings Bundle. Each recorded session is worth 1.0 E-CERP.

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. 

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

All pricing listed in USD. If you are eligible for equity pricing, please use the discount codes below. Your registration may be revoked if you use a registration code for which you are not eligible.

To determine the country category that matches the country in which you reside, click here.

ILCA's 2022 AGM: Recorded 13 July 2022

ILCA's 2021 AGM: Recorded 12 August 2021

Accelerating the Achievement of Global Breastfeeding Targets (E-CERP)

Overview:

Dr. Francesco Branca, MD, PhD, Director of the Department of Nutrition for Health & Development in the World Health Organization in Geneva, discusses new challenges on the protection from marketing infant formula and how to make health facilities more conducive to breastfeeding.

Upon completion, the learner will be able to:

1. Identify new challenges on the protection from marketing infant formula

2. Explain the global importance and status of breastfeeding

3. Discuss how to make health facilities more conducive to breastfeeding

Credit: 1.00 E CERPs and 1.00 Contact Hours

Source: ILCA Conference - 1-2 September 2021 (Houston, Texas, US)

Presented by: Francesco Branca, MD, PhD, World Health Organization

Learning Level: Beginner, Intermediate, Advanced

Expiration Date: 31 July 2024

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare. The presenter has no significant financial interest or other relationship with the manufacturer(s) of any product(s) or provider(s) of any services relating to the subject matter of this presentation unless otherwise stated in the presentation.

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

ANCC: ILCA is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Approval Number ILCA-P0286. Accepted for BRN credit by the Board of Registered Nursing.

Independent Study Module for International Board Certified Lactation Consultants^®

Title: The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination

Author(s): Hannah G. Juncker, MD, Sien J. Mulleners, BSc, Marit J. van Gils, PhD, Christianne J. M. de Groot, MD, PhD, Dasja Pajkrt, MD, PhD, Aniko Korosi, PhD, Johannes B. van Goudoever, MD, PhD, and Britt J. van Keulen, MD

Source: Journal of Human Lactation: 37(3) 2021

After completing this study module, the learner will be able to:

1. Describe the progression of SARS-CoV-2 antibodies in the breast milk of vaccinated lactating women

2. Identify the possible impact of antibodies in human milk on lactating women's decision to obtain COVID vaccination

3. List the benefits of human milk related to infection

1 L-CERP and contact hour(s)

IBLCE Category: Pharmacology & Toxicology

KEY TIPS FOR COMPLETING THIS MODULE:

1. Be sure to read the article more than once.

2. Read key messages and charts within the article.

3. Reference the article as you answer the questions.

4. Pay attention to keywords in the question prompt to help in locating the article section which contains the answer.

5. Reference the learning objectives of the study module in order to answer questions.

You will have two attempts to achieve a passing score of 70% on this module.

Expires: 12 May 2025

--------------------------------------------------------------------------------

Disclosures: ILCA accepts no commercial support for continuing education activities. The activity planners have no conflicts of interest to declare.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

CERPs: ILCA is an approved provider of Continuing Education Recognition Points (CERPs) with the International Board of Lactation Consultant Examiners (IBLCE). (CLT-108-7).

ANCC: ILCA is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Approval Number ILCA-P0286. Accepted for BRN credit by the Board of Registered Nursing.